Sunesis Pharmaceuticals (SNSS) Reports Q3 Loss of 21c
Tweet Send to a Friend
Sunesis Pharmaceuticals (Nasdaq: SNSS) reports Q3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
